These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mapping the ligand-binding site on the C5a receptor: arginine74 of C5a contacts aspartate282 of the C5a receptor. Cain SA; Coughlan T; Monk PN Biochemistry; 2001 Nov; 40(46):14047-52. PubMed ID: 11705397 [TBL] [Abstract][Full Text] [Related]
4. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. Heller T; Hennecke M; Baumann U; Gessner JE; zu Vilsendorf AM; Baensch M; Boulay F; Kola A; Klos A; Bautsch W; Köhl J J Immunol; 1999 Jul; 163(2):985-94. PubMed ID: 10395696 [TBL] [Abstract][Full Text] [Related]
5. A selection system to study C5a-C5a-receptor interactions: phage display of a novel C5a anaphylatoxin, Fos-C5aAla27. Hennecke M; Kola A; Baensch M; Wrede A; Klos A; Bautsch W; Köhl J Gene; 1997 Jan; 184(2):263-72. PubMed ID: 9031638 [TBL] [Abstract][Full Text] [Related]
6. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis. Kola A; Baensch M; Bautsch W; Hennecke M; Klos A; Casaretto M; Köhl J Immunotechnology; 1996 Jun; 2(2):115-26. PubMed ID: 9373320 [TBL] [Abstract][Full Text] [Related]
7. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor. Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341 [TBL] [Abstract][Full Text] [Related]
8. A detailed analysis of the C5a anaphylatoxin effector domain: selection of C5a phage libraries on differentiated U937 cells. Hennecke M; Otto A; Baensch M; Kola A; Bautsch W; Klos A; Köhl J Eur J Biochem; 1998 Feb; 252(1):36-44. PubMed ID: 9523709 [TBL] [Abstract][Full Text] [Related]
9. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). Cain SA; Monk PN J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063 [TBL] [Abstract][Full Text] [Related]
10. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor. Raffetseder U; Röper D; Mery L; Gietz C; Klos A; Grötzinger J; Wollmer A; Boulay F; Köhl J; Bautsch W Eur J Biochem; 1996 Jan; 235(1-2):82-90. PubMed ID: 8631370 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the C5a anaphylatoxin core domain using a C5a phage library selected on differentiated U937 cells. Kola A; Baensch M; Bautsch W; Klos A; Köhl J Mol Immunol; 1999 Feb; 36(2):145-52. PubMed ID: 10378686 [TBL] [Abstract][Full Text] [Related]
12. Site directed mutagenesis of the complement C5a receptor--examination of a model for its interaction with the ligand C5a. Pease JE; Burton DR; Barker MD Mol Immunol; 1994 Jul; 31(10):733-7. PubMed ID: 8035835 [TBL] [Abstract][Full Text] [Related]
13. Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor. Cain SA; Woodruff TM; Taylor SM; Fairlie DP; Sanderson SD; Monk PN Biochem Pharmacol; 2001 Jun; 61(12):1571-9. PubMed ID: 11377387 [TBL] [Abstract][Full Text] [Related]
14. An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. Zaccolo M; Williams DM; Brown DM; Gherardi E J Mol Biol; 1996 Feb; 255(4):589-603. PubMed ID: 8568899 [TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and expression of the functional rat C5a receptor. Rothermel E; Zwirner J; Vogt T; Rabini S; Götze O Mol Immunol; 1997; 34(12-13):877-86. PubMed ID: 9464523 [TBL] [Abstract][Full Text] [Related]
16. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor. Tardif M; Brouchon L; Rabiet MJ; Boulay F Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272 [TBL] [Abstract][Full Text] [Related]
17. Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin. Chen Z; Zhang X; Gonnella NC; Pellas TC; Boyar WC; Ni F J Biol Chem; 1998 Apr; 273(17):10411-9. PubMed ID: 9553099 [TBL] [Abstract][Full Text] [Related]
18. Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding. Zhang X; Boyar W; Galakatos N; Gonnella NC Protein Sci; 1997 Jan; 6(1):65-72. PubMed ID: 9007977 [TBL] [Abstract][Full Text] [Related]
19. Derivation of ligands for the complement C3a receptor from the C-terminus of C5a. Halai R; Bellows-Peterson ML; Branchett W; Smadbeck J; Kieslich CA; Croker DE; Cooper MA; Morikis D; Woodruff TM; Floudas CA; Monk PN Eur J Pharmacol; 2014 Dec; 745():176-81. PubMed ID: 25446428 [TBL] [Abstract][Full Text] [Related]
20. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization. Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]